The medical tourism market is estimated to be valued at USD 16.51 Bn in 2025 and is expected to reach USD 39.84 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.4% from 2025 to 2032.
The medical tourism market is expanding rapidly as patients increasingly travel across borders to receive medical care while combining treatment with travel and recovery. High healthcare costs in developed countries, growing demand for elective procedures such as cosmetic and dental treatments, and the availability of advanced medical technologies in popular destinations are driving this growth. Enhanced accessibility through online consultations and travel facilitation, along with patients’ preference for shorter waiting times, high-quality care, and integrated healthcare-tourism services, is further accelerating the market worldwide.
|
Current Events |
Description and its impact |
|
Geopolitical Developments |
|
|
Technological Innovations |
|
|
Socio-Demographic Shifts |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Private hold the largest market share of 68.3% in 2025. The private sector drives the medical tourism market growth by delivering affordable, high-quality healthcare that attracts international patients. Private hospitals and clinics use advanced technology, specialized treatments, and international accreditations to establish trust and enhance their reputation. They offer faster access, personalized care, and comprehensive packages that combine medical treatment with travel and accommodation. By adopting flexible business models, executing targeted marketing, and forming strategic partnerships, the private sector quickly meets global demand and strengthens the expansion of medical tourism worldwide. For instance, in February 2025, Doctors and healthcare leaders praised Finance Minister Nirmala Sitharaman’s Budget plan to promote medical tourism in India through private-sector partnerships, capacity building, and easier visa norms.
Cosmetic Treatment acquired the prominent market share of 42.6% in 2025. Patients seeking affordable, high-quality aesthetic procedures abroad are driving the growth of cosmetic treatments in medical tourism. Growing awareness of beauty and wellness, along with social media influence, boosts demand for both surgical and non-invasive procedures. Destinations with skilled surgeons, advanced technologies, and accredited facilities attract international clients. By offering shorter waiting times, personalised care, and integrated packages that combine treatment with travel and recovery, providers enhance their appeal. Rising disposable incomes and the desire for improved appearance make cosmetic procedures a major focus in medical tourism. For instance, in October 2025, Egypt unveiled its unified digital health tourism platform at the Global Conference on Health, Development, and Population, featuring licensed providers in dental care, cosmetic surgery, and rehabilitation. Such innovations are accelerating the medical tourism market share.

To learn more about this report, Download Free Sample
North America dominates the overall market with an estimated share of 39.3% in 2025. Patients in North America are increasingly driving the medical tourism market by seeking cost-effective and timely healthcare abroad. High domestic treatment costs, long wait times, and limited insurance coverage motivate them to travel internationally. Growing awareness of global healthcare options, along with improved travel connectivity and online consultation platforms, makes accessing cross-border care easier. Elective procedures, cosmetic surgeries, and dental treatments fuel outbound demand, while nearby countries offering quality care add convenience, reinforcing North America’s position as a major source market in medical tourism.
Patients are driving the Asia Pacific medical tourism market by seeking affordable, high-quality healthcare and advanced medical technologies. Countries in the region actively promote specialized treatments such as cosmetic surgery, dental care, and cardiology through internationally accredited hospitals and skilled medical professionals. Governments enhance accessibility with favorable policies, streamlined visa processes, and well-developed travel infrastructure. By offering cost savings, superior service, and the chance to explore tourist destinations, the region attracts international patients and establishes itself as a leading hub for global medical tourism. For instance, in September 2025, the Kerala government launched a health insurance initiative to offer affordable coverage for expatriates and strengthen the state’s medical tourism industry.
Patients are shaping the United States medical tourism market revenue by seeking specialized, high-quality healthcare that is costly or limited domestically. Advanced medical technologies, expert physicians, and accredited hospitals draw both inbound and outbound patients. High treatment costs and long waiting times prompt Americans to pursue international options for elective procedures, dental care, and cosmetic surgeries. Simultaneously, the U.S. attracts international patients for complex treatments and innovative therapies, offering well-established healthcare infrastructure, efficient services, and integrated travel and care packages. For instance, in June 2025, Aditya Oza and Mikhail Bohra launched Luxora, a platform that streamlines medical travel for patients from the U.S., U.K., and Australia to global healthcare destinations.
Patients' desire for cutting-edge, superior healthcare combined with cutting-edge technologies is fueling the expansion of Japan's medical tourism industry. Through internationally recognized facilities and highly qualified medical personnel, the nation aggressively promotes specialist therapies like cancer therapy, regenerative medicine, and cosmetic surgeries. Access for overseas patients is facilitated by effective healthcare services, robust government backing, and simplified medical visa procedures. Additionally, Japan's safety, cleanliness, and cultural experiences draw tourists, enticing them to combine medical treatment with travel and solidifying Japan's position as a leading provider of advanced medical care. For instance, in October 2025, Japan’s largest travel agency, JTB, partnered with Hawaii Tourism Japan to promote medical and wellness tourism between Japan and Hawaii, offering quality healthcare and wellness services to travelers.
Patients from developed countries increasingly seek affordable healthcare abroad due to high domestic costs and long waiting times. Elective procedures, cosmetic surgeries, and dental treatments are major motivators. Enhanced digital awareness, telemedicine consultations, and travel facilitation platforms empower patients to plan international treatments efficiently, making outbound medical tourism a key trend shaping global healthcare consumption patterns.
Countries are positioning themselves as hubs for specific medical specialties such as cardiology, orthopedics, fertility, and cosmetic surgery. By investing in advanced infrastructure, internationally accredited hospitals, and skilled medical professionals, destinations can attract international patients seeking high-quality, specialized care. Focused specialization enhances patient trust and drives targeted marketing in the competitive medical tourism landscape.
Emerging economies are investing in healthcare infrastructure, attracting international patients with cost-effective, high-quality treatments. Countries like India, Thailand, and Malaysia are developing specialized medical hubs, creating opportunities for new market entrants. By leveraging affordable services, skilled professionals, and tourism potential, these destinations can capture global patient demand, offering a competitive alternative to traditional markets while expanding the geographic footprint of medical tourism.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 16.51 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 13.4% | 2032 Value Projection: | USD 39.84 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
MOHW Hengchun Tourism Hospital, Apollo Hospitals Enterprise Ltd., Bumrungrad International Hospital, Mount Elizabeth Hospitals, Raffles Medical Group, Dr. B. L. Kapur Memorial Hospital, Kasemrad Hospital International Rattanathibet, Mission Hospital, Bangkok Hospital, Miot Hospital, Penang Adventist Hospital, Aditya Birla Memorial Hospital, Asian Heart Institute, Barbados Fertility Center, Fortis Healthcare Limited, KPJ Healthcare Berhad, NTT Medical Center Tokyo, and Prince Court Medical Centre |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
About Author
Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.
Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients